Friday, 8th March ASGO Annual Scientific Meeting 2024

Topic: HRD Testing: The Australian Real-World Experience

Proudly supported by AstraZeneca
Friday March 8 | 7:00-8:00am AEDT
Federation Ballroom, Hotel Grand Chancellor Hobart

HRD testing has been available to patients with newly diagnosed, advanced high-grade epithelial ovarian cancer since June last year. Most patients have been tested at the lab in Peter Mac, providing a dataset of over 700 patients to review testing performance in the first 8 months since introduction.

Learn from Dr Toni Jones and Dr Andrew Fellowes as they unpack this dataset and what impact this may have on the clinical management of these patients.

7:00am - Opening & Welcome - Dr Toni Jones 
7:05am - Topic 1: HRD Real World Evidence from the Peter Mac lab - Dr Andrew Fellowes
7.30am - Topic 2: A comment on this data for clinical practice - Dr Toni Jones 
7.45am - Q&A - Hosted by Dr Toni Jones 
8.00am - Meeting close 

Breakfast will be provided on entry.

• Disparities in Funding for Research - Robin Penty
• Treatment of Cancer in Resource Limited Settings - Rene Pareja
• Let’s Talk Sustainability…In the Operating Theatre - Penny Blomfield
• Job Satisfaction and the Modern Workplace - Hannah Forsyth
• Karl Storz Sponsor Presentation - Leigh Whitehead

• The role of p53 and p16 immunohistochemistry in vulval cancer prognosis - Helena M Obermair
• Node-positive Carcinoma of Vulva Treated with Curative-Intent Radiotherapy:  Reported Outcomes from a Large Single Australian Institution - Ming-Yin Lin
• Patterns of surgical care for patients with sex cord-stromal tumours in the National Gynae-Oncology Registry (NGOR) in Australia - Michael Burling
• A practical illustration of sentinel lymph node (SLN) mapping for vulvar cancer using indocyanine green (ICG). - Michael Burling
• Effect of a multidisciplinary approach to placenta accreta spectrum at a tertiary obstetric hospital - Michael Yu
• Robotic assisted radical hysterectomy and sentinel node mapping for early-stage Cervical cancer using the Mc Cartney Tube to prevent tumour spillage. - Felix Chan
• B Braun Sponsor Presentation - Marcelle Healy

• Hyperbaric O2 Therapy for Cervical and Vulval Cancers - Davdi Cooper
• Anal Cancer in the Spectrum of Gynaecological Oncology - Richard Turner
• Arthrex Sponsor Presentation  - Kim Collings

MONA: Meet at the Brooke Street Pier at 2.00pm for 2.15pm departure. Return ferry leaving MONA at 5.00pm

Golf: As per information already advised

Tennis: As per information already advised